ArticleFood science & nutrition2025
ALA Alleviates Liver Damage in Septic Mice Through PI3K/AKT Signaling Pathway.
Article in Food science & nutrition, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Maresin-1 Alleviates Sepsis-Induced Liver Injury by Regulating Apoptosis and Autophagy via Activation of the PI3K/Akt Signaling Pathway in Mice.Current issues in molecular biology · 2026Article
- Article
- ALA Alleviates Liver Damage in Septic Mice Through PI3K/AKT Signaling Pathway.Food science & nutrition · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Sepsis is a life-threatening systemic inflammatory response syndrome that arises from infection and frequently progresses to multi-organ dysfunction, with liver injury being a particularly significant manifestation. Alpha-lipoic acid (ALA), renowned for its potent antioxidant and anti-inflammatory properties, has demonstrated promising protective effects in sepsis. The present study aims to investigate the protective effects of ALA on liver damage in septic mice by modulating the PI3K/AKT signaling pathway, thereby providing novel therapeutic strategies for the treatment of sepsis. The cecal ligation and puncture (CLP) model was employed to induce sepsis in mice, and both ALA-treated and control groups were established. The protective effects of ALA were evaluated through the detection of PI3K/AKT signaling pathway-related protein expression, apoptosis in liver cells, and liver function indicators. Additionally, Western blotting and immunohistochemistry were utilized to further validate ALA's regulatory impact on the PI3K/AKT signaling pathway. The study revealed that ALA significantly enhanced the activation of the PI3K/AKT signaling pathway, reduced apoptosis in liver cells of septic mice, and improved liver function indicators. Moreover, liver tissue pathology in the ALA-treated group was markedly less severe compared to that in the control group, indicating its effective hepatoprotective action. These findings demonstrate that ALA effectively alleviates liver damage in septic mice by promoting the PI3K/AKT signaling pathway, highlighting its potential clinical value. This research provides new targets and insights for the development of therapeutic strategies for sepsis.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.